抑制性KIR配体与恶性疟原虫寄生虫血症高患病率相关
该研究在890名乌干达个体的纵向队列中分析KIR-HLA复合基因型与恶性疟原虫感染风险的关系,发现HLA-C2和HLA-Bw4(分别为抑制性KIR2DL1和KIR3DL1的配体)以累加方式增加寄生虫血症可能性,HLA-C2纯合子几率最高,HLA-C1纯合子最低,HLA-C表面高表达也与更高寄生虫血症可能性相关。
要点
- HLA-C2和HLA-Bw4配体以累加方式增加恶性疟原虫寄生虫血症风险。
- HLA-C2纯合子寄生虫血症几率最高,HLA-C1纯合子最低。
- HLA-C表面高表达与更高寄生虫血症可能性相关。
核心结论
- 更强的KIR介导抑制赋予恶性疟原虫寄生虫血症更高风险,提示表达KIR的效应细胞参与抗寄生虫免疫。
研究设计与样本
- 研究分析了890名乌干达个体纵向队列中KIR-HLA复合基因型与恶性疟原虫感染风险的关系。
主要发现
- HLA-C2和HLA-Bw4(分别为抑制性KIR2DL1和KIR3DL1的配体)以累加方式增加恶性疟原虫寄生虫血症可能性。
- HLA-C2纯合子(经KIR2DL1介导强抑制)寄生虫血症几率最高,HLA-C1/C2杂合子居中,HLA-C1纯合子(经KIR2DL2/3介导较弱抑制)最低。
- HLA-C(抑制性KIR2DL1/2/3的配体)表面表达越高,寄生虫血症可能性越高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Killer cell immunoglobulin-like receptors (KIRs) and their HLA ligands influence the outcome of many infectious diseases. We analyzed the relationship of compound KIR-HLA genotypes with risk of Plasmodium falciparum infection in a longitudinal cohort of 890 Ugandan individuals. We found that presence of HLA-C2 and HLA-Bw4, ligands for inhibitory KIR2DL1 and KIR3DL1, respectively, increased the likelihood of P. falciparum parasitemia in an additive manner. Individuals homozygous for HLA-C2, which mediates strong inhibition via KIR2DL1, had the highest odds of parasitemia, HLA-C1/C2 heterozygotes had intermediate odds, and individuals homozygous for HLA-C1, which mediates weaker inhibition through KIR2DL2/3, had the lowest odds of parasitemia. In addition, higher surface expression of HLA-C, the ligand for inhibitory KIR2DL1/2/3, was associated with a higher likelihood of parasitemia. Together these data indicate that stronger KIR-mediated inhibition confers a higher risk of P. falciparum parasitemia and suggest that KIR-expressing effector cells play a role in mediating antiparasite immunity.
引用
- Digitale JC, Callaway PC, Martin M, et al. Association of Inhibitory Killer Cell Immunoglobulin-like Receptor Ligands With Higher Plasmodium falciparum Parasite Prevalence. J Infect Dis. 2021. PMID: 33165540. doi:10.1093/infdis/jiaa698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。